Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts. - Wikidata - awgldk - TriplyDB

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

http://www.wikidata.org/entity/Q34223860

about

Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges CCR9 in cancer: oncogenic role and therapeutic targeting CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.92R Monoclonal Antibody Inhibits Human CCR9+ Leukemia Cells Growth in NSG Mice Xenografts.

P2860

Q26866236-82AD758F-9A99-4E6F-860D-44E2A93EF449 Q28066712-10BAF30B-6FDC-4CBA-ABFA-23F948F9184A Q38908550-CA1DC2D0-D236-40D8-A683-CA6D23C8981E Q49539698-2AD31421-6778-43CE-952F-1D4D01909E26 Q50054520-D2D562F9-EA4C-4020-B099-F1FF70CFBCD2

P2860

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

http://www.wikidata.org/entity/Q34223860

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

@ast

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

@en

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

@nl

type

label

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

@ast

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

@en

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

@nl

prefLabel

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

@ast

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

@en

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

@nl

P1433

Q34223860-80800532-21EF-4D19-B206-1663034B86C1

P1476

Q34223860-BF005423-BAC4-4D49-81DE-064197D5B934

P2093

Q34223860-478CCFB4-4F57-4FCD-8A65-37BEE125D2A0

Q34223860-7335CA35-D080-4589-8E0D-46EE9D8B957B

Q34223860-8D22DE70-E785-4C3D-83CE-9CD540DCFAD1

Q34223860-AD6330B0-3B59-4989-9A2F-636979AA32FA

Q34223860-B16D1D0C-708E-4937-8B64-EA4BC672B3C9

Q34223860-C2AB3EE4-6E16-4983-B699-EF133BD26A87

Q34223860-D4EC2D38-4F3A-4324-B1AC-35BB8EF53BA4

Q34223860-DC0496BC-5D96-41DD-ABA7-A1E92DBC1408

P2860

Q34223860-0272771F-8030-40FD-9CF3-B159AEDEF3F3

Q34223860-131AAF26-C192-4371-9A1A-20055441B417

Q34223860-13DC8B68-287C-4C3F-8F54-FB48F179305F

Q34223860-1AA6AC66-02F0-43A1-BB2C-6310B7965B18

Q34223860-206738E7-5136-4EA0-A2F3-568C650B30E5

Q34223860-21C57E7B-284C-4E42-81C4-69B6B64580CA

Q34223860-237AE0DE-ACE2-46FB-B041-8641DAC2BE07

Q34223860-2783D7CE-BE6E-43F1-846D-9E37BFC3B015

Q34223860-2F098C48-72BD-4987-BE2E-20F8649FB70C

Q34223860-3789F782-2BB0-45BF-BCBC-6D43B8E675D8

P304

Q34223860-666F24E5-1E3D-43F1-B4BA-3C9EB7ED4677

P31

Q34223860-0E4E0676-1901-41F5-AC96-B48889F17B4F

P356

Q34223860-4A7F6738-16E2-4E13-A056-32B5250F3E70

P433

Q34223860-4DACC126-356F-4C37-B415-90F39225E02B

P478

Q34223860-E6F6E03D-1C6B-49C3-9358-4F2E3C9F224A

P50

Q34223860-007898EA-51F9-4DB7-BD10-E28FF54A7657

Q34223860-2427A4FD-7A89-4A1E-B07B-0CB896F43773

Q34223860-D74A1ECB-7885-4BB5-9BF2-DA520938DB00

P577

Q34223860-D41D5EAF-5BDC-48C3-B2CE-BAA8F382D795

P5875

Q34223860-2D8C4272-D0A1-4472-8122-342252FD16B3

P698

Q34223860-5D6499AF-E229-4251-8D5E-E03B569C69DB

P921

Q34223860-4AE22FEE-00AD-40FA-96A8-EA46A275B912

Q34223860-E26E352E-A676-4D96-8D6E-2A427AEF6906

P932

Q34223860-D4E25AEE-848C-4CF0-8CAB-D8C9DD10D192

P356

P1433

Monoclonal Antibodies

P1476

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts.

@en

P2093

Ana Franco-Villanueva

http://www.w3.org/2001/XMLSchema#string

Beatriz Salvador

http://www.w3.org/2001/XMLSchema#string

Carlos Martínez-A

http://www.w3.org/2001/XMLSchema#string

Julio Gutiérrez

http://www.w3.org/2001/XMLSchema#string

Lucio Gómez

http://www.w3.org/2001/XMLSchema#string

María Lozano

http://www.w3.org/2001/XMLSchema#string

Mónica García-Gallo

http://www.w3.org/2001/XMLSchema#string

Sonia Chamorro

http://www.w3.org/2001/XMLSchema#string

P2860

Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies

Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK

Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis

TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity

Angiogenesis in cancer and other diseases

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9

TECK, an efficacious chemoattractant for human thymocytes, uses GPR-9-6/CCR9 as a specific receptor

P304

1000-1012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/MABS.29063

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Laura Carramolino

P577

2014-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262069408

http://www.w3.org/2001/XMLSchema#string

P698

24870448

http://www.w3.org/2001/XMLSchema#string

P921

P932

4171004

http://www.w3.org/2001/XMLSchema#string